Objective: Provide a unified conceptual framework for describing, comparing, and designing logic-gated cancer therapies across CAR-T and nanocarrier platforms.
Why it works: The framework is expected to work because it organizes both CAR-T and nanocarrier systems using shared design dimensions, enabling systematic comparison beyond structural logic architecture alone.
Priority logic: The review prioritizes common design dimensions that can be applied across modalities: logic architecture, molecular implementation, logic behavior, and the therapeutic stage at which gating occurs.
Validation strategy: The abstract describes comparative interpretation across modalities rather than experimental validation.
Target properties: specificity, context-restricted activation, logic behavior, threshold behavior, temporal activation dynamics, reduced on-target off-tumor toxicity
Target mechanisms: integration of multiple biological inputs to control therapeutic activation, Boolean logic gating using AND, OR, and NOT operations, signal propagation and amplification shaping activation behavior
Target techniques: cross-platform comparative analysis, framework formalization, terminology unification